Stage IVA Hepatocellular Carcinoma AJCC V8

specific

Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)

35

Centers

40

Active Trials

Cancer Funding

Top Centers for Stage IVA Hepatocellular Carcinoma AJCC V8(35)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
70.1
2
NCI Comprehensive
High-Volume Research Center
70.1
3
High-Volume Research Center
70.1
4
High-Volume Research Center
70.1
5
High-Volume Research Center
70.1
6
High-Volume Research Center
70.1
7
NCI Comprehensive
Active Research Program
48.2
8
NCI Comprehensive
Active Research Program
48.2
9
NCI Comprehensive
Active Research Program
48.2
10
NCI Comprehensive
Active Research Program
48.2
11
NCI Comprehensive
Active Research Program
48.2
12
NCI Comprehensive
Active Research Program
48.2
13
NCI Comprehensive
Active Research Program
48.2
14
NCI Comprehensive
Active Research Program
48.2
15
NCI Comprehensive
Active Research Program
48.2
1648.2
17
NCI Comprehensive
Active Research Program
48.2
18
NCI Comprehensive
Active Research Program
48.2
19
NCI Comprehensive
Active Research Program
48.2
20
NCI Comprehensive
Active Research Program
48.2
21
NCI Comprehensive
Active Research Program
48.2
22
NCI Clinical
Active Research Program
48.2
23
Active Research Program
48.2
24
NCI Clinical
Active Research Program
48.2
25
NCI Comprehensive
Active Research Program
48.2
26
NCI Comprehensive
Active Research Program
48.2
27
NCI Clinical
Active Research Program
48.2
28
Active Research Program
48.2
29
NCI Comprehensive
Active Research Program
48.2
30
Active Research Program
48.2
31
Active Research Program
48.2
32
Active Research Program
48.2
33
Active Research Program
48.2
34
Active Research Program
48.2
35
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
29.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →